Dudediligence.

Eton Pharmaceuticals, Inc

ETONNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$10.3MSep ’24$11.6MDec ’24$17.3MMar ’25$18.9MJun ’25$22.5MSep ’25$21.3MDec ’25$24.3MMar ’26$37.6MJun ’26
Net income, by quarter
$627,000Sep ’24−$598,000Dec ’24−$1.6MMar ’25−$2.6MJun ’25−$1.9MSep ’25$1.5MDec ’25$1.6MMar ’26$11.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$21.8M$21.3M$31.6M$39.0M$80.0M
Gross profit$19.0M$14.3M$21.1M$23.4M$42.7M
Operating income−$1.5M−$8.3M−$1.2M−$2.6M−$844,000
Net income−$2.0M−$9.0M−$936,000−$3.8M−$4.6M
Operating cash flow−$4.7M$4.8M$6.8M$969,000$10.5M
Free cash flow−$4.7M$4.8M$6.8M$943,000$10.2M
Cash$14.4M$16.3M$21.4M$14.9M$25.9M
Debt$6.7M$6.4M$5.4M$29.8M$30.6M
Shares outstanding24.6M25.4M25.7M26.7M27.0M